Prescription Alternatives
Page 65
Riggs, B. L., et al. “Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis.” New England Journal of Medicine 322 (1990): 802–9.
Scarbeck, K. “Strength Training May Reduce the Risk of Osteoporotic Fractures.” Family Practice News (February 15, 1995): 10.
Sowers, M. F. R., et al. “A Prospective Study of Bone Mineral Content and Fracture in Communities with Differential Fluoride Exposure.” American Journal of Epidemiology 134 (1991): 649–60.
Yang, Y. X., and J. D. Lewis, et al. “Long-Term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.” Journal of the American Medical Association 296, no. 24 (December 27, 2006): 2947–53.
Chapter 23
Drugs for Attention Deficit/Hyperactivity Disorder and Their Natural Alternatives
Alonzo-Zaldivar, R. “FDA Calls for Improved Warnings for ADD Drugs.” Washington Times, March 22, 2006.
Bateman, B. “The Effects of a Double-Blind, Placebo Controlled, Artificial Food Colorings and Benzoate Preservative Challenge on Hyperactivity in a General Population Sample of Preschool Children.” Archives of Disease in Childhood 89 (2004): 506–11.
Bellanti J., W. G. Crook, and R. E. Layton. “Attention Deficit Hyperactivity Disorder: Causes and Possible Solutions.” From Conference of Georgetown University, the International Center for Interdisciplinary Studies of Immunology, and the International Health Foundation at Key Bridge Marriot Hotel, Arlington, VA, November 4–7, 1999.
Boris, M., and F. S. Mandel. “Foods and Additives Are Common Causes of the Attention Deficit Hyperactive Disorder in Children.” Annals of Allergy 72, no. 5 (May 1994): 462–68.
Breggin, Peter, “Psychostimulants in the Treatment of Children Diagnosed with ADHD: Risks and Mechanism of Action.” International Journal of Risk & Safety in Medicine 12 (1999): 3–35.
Burgess, J. R., et al. “Long-Chain Polyun-saturated Fatty Acids in Children with Attention-Deficit Hyperactivity Disorder.” American Journal of Clinical Nutrition 71, supp. 1 (January 2000): 327S–30S.
Carter, C. M., et al. “Effects of a Few Food Diet in Attention Deficit Disorder.” Archives of Disease in Childhood 69, no. 5 (November 1993): 564–68.
Crook, W. G. “Sugar and Children’s Behavior.” New England Journal of Medicine 330, no. 26 (June 30, 1994): 1901–2.
DeNoon, Daniel. “Ritalin for Preschoolers? Study Shows Drug Provides ‘Moderate’ Help for Preschool Kids with ADHD.” WebMD Medical News, October 19, 2006.
Grandjean P., and P. J. Landrigan. “Developmental Neurotoxicity of Industrial Chemicals.” The Lancet 368, no. 9553 (November 8, 2006): 2167–78.
Greenhill, L. “Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD.” Journal of the American Academy of Child and Adolescent Psychiatry 45 (November 2006: 1284–93.
Parker-Pope, Tara. “Studies Linking Ritalin and Depression Highlight Risk of Overdiag-nosing ADHD.” Wall Street Journal (January 25, 2005): D1.
Price, J. H. “FDA Orders Drug Warnings for ADHD Patients.” Washington Times (February 22, 2007).
Rubin, R. “FDA Panel: ADHD Drugs for Kids Need Hallucination Warning.” USA Today (March 23, 2006): 6D.
Sabra, A., J. A. Bellanti, and A. R. Colon. “Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children.” The Lancet 352, no. 9123 (July 18, 1998): 234–35.
Schoenthaler, S. J., and I. D. Bier. “The Effect of Vitamin-Mineral Supplementation on Juvenile Delinquency Among American Schoolchildren: A Randomized, Double-Blind Placebo-Controlled Trial.” Journal of Alternative and Complementary Medicine 6, no. 1 (February 2000): 7–17.
Science News Daily. “Many Children Discontinuing Use of ADHD Medication.” December 17, 2006. http://www.science daily.com/releases/2006/12/061216104616.htm.
Stagnitti, M. N. “Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004.” Medical Expenditure Panel Survey (February 2007): Statistical Brief #163.
Uhlig, T., et al. “Topographic Mapping of Brain Electrical Activity in Children with Food-Induced Attention Deficit Hyperkinetic Disorder.” European Journal of Pediatrics 156, no. 7 (July 1997): 557–61.
Vedantam, Shankar. “Warning Urged for ADHD Drugs.” The Washington Post, February 10, 2006: A1.
Wakefield, A. J. “The Gut-Brain Axis in Childhood Developmental Disorders.” Journal of Pediatrics Gastroenterology and Nutrition 34, supp. 1 (May/June 2002): S14–7.
Reference Books
Bosker, G., M.D., FACEP. Pharmatecture: Minimizing Medications to Maximize Results. St. Louis, MO: Facts & Comparisons, 1996.
Colvin, R. Prescription Drug Abuse: The Hidden Epidemic. Omaha, NE: Addicus Books, 1995.
Drug Facts & Comparisons. St. Louis, MO: Facts & Comparisons, 2002.
Ganong, W. F. Review of Medical Physiology. 16th ed. Norwalk, CT: Appleton & Lange, 1993.
Gradeon, J., and T. Gradeon, Ph.D. The People’s Guide to Deadly Drug Interactions. New York: St. Martin’s Press, 1995.
_____. The People’s Pharmacy. New York: St. Martin’s Griffin, 1996.
Grahame-Smith, D. G., and J. K. Aronson. Oxford Textbook of Clinical Pharmacology and Drug Therapy. Oxford, England: Oxford University Press, 1992.
Handbook of Nonprescription Drugs. 11th ed. Washington, DC: American Pharmaceutical Association, 1996.
Hansten, P. D., and J. R. Horn. Hansten and Horn’s Drug Interactions Analysis and Management. Vancouver, WA: Applied Therapeutics, Inc., 1997.
Harness, R. H. Drug Interactions Guide Book. Englewood Cliffs, NJ: Prentice Hall, 1991.
Holt, G. Food and Drug Interactions: A Health Care Professional’s Guide. Chicago: Precept Press, Inc., 1992.
The Merck Manual of Diagnosis and Therapy. Rahway, NJ: Merck & Co., 1992.
Physicians’ Desk Reference. Montvale, NJ: Medical Economics Data Production Company, 1997.
The PDR Family Guide to Prescription Drugs. New York: Crown, 1996.
Thomas, J. H., and B. Gillham. Wills’ Biochemical Basis of Medicine. Oxford, England: Butterworth-Heineman Ltd., 1992.
INDEX
Acarbose, 286
Accupril, 109
ACE inhibitors, 109–10
antihypertensives and, 101
asthma and, 161
side effects of drugs, 109–10
Acebutolol, 106
Aceon, 109
Acetaminophen (Tylenol), 33, 58–59, 205
for children, 201
for fever, 191–92
food interactions, 205
for pain relief, 199, 201
side effects, 202, 205
Acetohexamide, 287
Acid secretion, 149–50
Aciphex, 142–43
Actonel, 352, 354
Actos, 289–90, 359
Actron, 207
Acupressure, 219
Acupuncture, 219
Acyclovir, 364
Adalat, 110
Adderall, 18, 19, 371, 373, 379–80
Adderall XR, 379–80
Addiction
antibiotics, 227
defining, 22–25
narcotics, 212
Addison’s disease, 180
ADEs. See Adverse drug events (ADEs)
ADHD. See Attention deficit/hyperactivity disorder (ADHD)
Adolescents. See also Children
antidepressants and, 253
prescription drug abuse, 14–15
Adrenalin Chloride (epinephrine), 176
Adrenergic agents, 309
Advair, 170–71
Adverse drug events (ADEs), 4–6, 43, 54, 386. See also Prescription drugs
drug categories associated with, 4
in hospitals, 62
statistics, 4, 6
Advil. See Ibuprofen (Advil)
Afrin, 176
Agency for Healthcare Research and Quality (AHRQ), 285, 324–25
Agi
ng. See also Elderly
diabetes and, 303–4
Ahlgrimm, Marla, 334
Akathisia, 255
AKBeta, 311–13
Alcohol
antihistamines and, 174
avoiding to fight infection, 245
benzodiazepines and alcoholics, 262
depression and, 271
drugs and, 39, 40–41
heart disease and, 82
immune system and, 197
osteoporosis and, 359
penicillin and, 232
surgery and, 59
Alconefrin (phenylephrine), 176
Aldactazide, 105
Aldactone, 105
Aldomet, 112
Alendronate, 354
Aleve. See Naproxen (Aleve)
Alexander technique, 219
Alfentanil (Alfenta), 212
Alfuzosin, 328
Alka-Seltzer, 206
All Children Flourishing: Igniting the Greatness of Our Children (Glasser), 384
Allegra, 173
Allerest (oxymetazoline), 176
Allergies
alternative medicines for, 185–87
childhood exposures and, 158
drugs for, 172–75
eye allergies, 320–21
identifying, 156–59
immune system, 197
precautions, 183–85
Allermed (pseudoesphedrine), 176
ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), 101–2
Alli, 297–98
Almarl, 107
Almotriptan malate (Axert), 210
Alpha-1 blockers, 114, 328
Alpha/beta adrenergic blockers, 107–9
Alphagan, 309–11
Alpha-glucosidase inhibitors, 286
Alpha-lipoic acid (thioctic acid), 59, 304
Altace, 109
Alternative medicine
allergies, 183–87
antibiotic alternatives, 243–49
asthma, 187–90
attention deficit/hyperactivity disorder (ADHD), 380–84
blood clots, 97–98
blood pressure, 116–19
carpal tunnel syndrome, 224–25
colds, 191–97
versus conventional medicine, 9–11
depression, 271–72, 277–81
diabetes, 298–302
diarrhea, 148
eye diseases, 318–21
flu, 191–97
headaches, 219–21
heart disease, 82–94
heartburn, 149–50
herpes, 365–66
impotence, 369–70
insomnia, 271–76
obesity, 298–302
pain relief, 214–25
prostate problems, 328–30
recommended reading, 386–87
strokes, 97–98
ulcers, 148–49
Altocor, 125–27
Altoprev, 125–27
Alu-Cap, 143
Aluminum, 359
Aluminum carbonate gel, 143–45
Aluminum hydroxide gel, 143
Alu-Tab, 143
Alzheimer’s disease, 84–85
Amantadine derivative antivirals, 242
Amaphen, 210
Amaryl, 287
Ambien, 251–52, 256–57
Ambien CR, 256–57
Amerge (naratriptan), 210
American College of Chest Physicians (ACCP), 175
American Diabetics Association, 299
American Gastroenterological Association, 201
American Heart Association, 123, 132
American Journal of Cardiology, 87
American Journal of Clinical Nutrition, 132, 202
American Journal of Epidemiology, 159
American Journal of Respiratory and Critical Care Medicine, 185
American Pain Foundation, 200
Amigesic (salicylsalicylic acid), 206
Amikacin, 240
Amiloride, 105
Amino acids, 280–81
absorption and drugs, 38–39
Aminoglycoside antibiotics, 240–41
kidney damage, 31
Aminophylline, 165–67
Amiodarone, 309
Amitone, 143
Amitriptyline, 262
Amlodipine, 110
Amoxicillin, 229, 231
Amoxil, 229
Amphetamine sulfate, 379–80
Amphetamines, 379–80
Amphojel, 143
Amphotericin B, 241
Ampicillin, 231
with probenecid, 231
and sulbactam, 231
Amyl nitrate, 95
Anacin, 209
Anafranil, 262
Anasaid (flurbiprofen), 207
Anderson, Richard, 302
Androderm patch, 338
Androgel, 338
Android, 338
Andropause, 367–70
Angina, 86–87
drugs for, 94–96
Angiotensin antagonists, 109–10
Angiotensin-converting enzyme inhibitors, 109
Anise, 186
Anisindione, 96
Anorexiants, 295–96
Antacids, 136, 143–45
antibiotics and, 230
caplets, 143
harm of, 150
Antazoline, 317
Antiadrenergic agents, 114
Antianxiety drugs, 260–62
drugs with potential for abuse, 20
withdrawal sypmtoms, 20
Antiarrhythmia drugs, 161
Antibiotics
antacids and, 230
antibiotic alternatives, 243–49
avoiding, 227
oral contraception and, 231
resistant bacteria, 228
statistics, 228
types, 229–331
Anticonvulsants, 372
Antidepressants, 262–71
abuse of, 19, 21
insomnia and, 274
osteoporosis and, 358–59
statistics, 253
Antidiarrhea drugs, 145–46
Antifungal agents, 229, 241–42
Antihistamines, 172–75
combinations, 173
eye problems, 309
side effects of drug, 173–74
Antihypertensives, 101–19. See also Specific types
safety, 101–2
side effects of drugs, 112–15
types, 101
Anti-infectives, 227. See also Antibiotics; Antifungal agents
Antioxidants, 60, 88–91
antioxidant levels, 80
asthma and, 187
Anti-Parkinson’s drugs, 161
Antipsychotic drugs, 161, 372
Antiviral drugs, 161, 242–43
Anxiety, 253–56
biochemical imbalance, 254
coffee, 272
statistics, 253
symptoms, 254
Anxiolytic benzodiazepines, 260–62
Appetite control drugs, 295–98
Apraclonidine, 309–11
Apresoline, 114
Aquazide, 102
Archives of Environmental Health, 187
Arginine, 366, 370
Arnica, 60
Arontinolol, 107
Arrhythmia, 94–96
Art of Simple Foods: Notes, Lessons, and Recipes from a Delicious Revolution (Waters), 382
Arthopan (choline salicylate), 206
Arthritis, 199, 202–3
drugs for, 214
natural remedies, 221–24
Ashwagandha, 277, 370
Aspirin, 206–7
asthma, 161
drug interactions with, 45
heart disease, 81–82
for pain relief, 199
prostate problems, 327
side effects, 202, 206
Asthma
alternative treatments, 187–90
causes of attacks, 190
drug interactions, 180
drugs for, 161–72
drugs that aggravate, 161
exercise-induced (EIA), 187
inhalers, 162, 338
Papworth method of controlling, 188
studies, 187–88
treating, 159–61
Astragalus, 365
Atacand, 109
Atenolol, 106
Athletic performance, 33
Ativan, 256
Atomoxetine, 379
Atorvastatin (Lipitor), 125–27
Atromid-S, 128–29
Atrovent, 170
Attention deficit/hyperactivity disorder (ADHD), 262, 371–84
adult, 18
alternative medicine, 380–84
children, 19, 372–73
diagnosis, 374
diet, 381–83
drugs for, 375–80
nutritional supplements, 383
parent education, 383–84
self-tests, 376
statistics, 371–73
studies, 381–82
testing, 373–74
Augmentin, 229
Avandia (rosiglitazone), 6, 289–90, 359
Avapro, 109
Avlocardyl, 107
Avodart, 327
Axert (almotriptan malate), 210
Axid, 141
Ayurvedic herbs, 301
Azithromycin, 238
Bacampicillin HCl, 231
Back pain, 21, 200, 204
Bacon, Patrick, 372
Banaba, 301–2
Bancap, 210
Barbiturates
abuse of, 20–21
asthma, 161
Barnidipine, 110
Basaljel, 143–45
Batmanghelidj, F., 189
Baycol (cerivastatin), 6
Bayer Select Maximum Strength Backache (magnesium salicylate), 206
Bayer Select Pain Relief (ibuprofen), 207
Baymycard, 110
Beclomethasone, 338
Beconase AQ (beclomethasone dipropionate), 177
Becotide, 338
Bee remedies, 187
Beet juice, 117
Behavioral Pharmacology, 262
Bell’s palsy, 363
Benazepril, 109
Bendroflumethiazide, 102
Benzodiazepines, 256, 260–62
abuse of, 19–20
asthma, 161
drugs with potential for abuse, 20
side effects, 262
withdrawal sypmtoms, 20
Benzphetamine HCl, 295
Benzthiazide, 102
Beta-2-adrenergic agonists, 309
Beta-adrenergic-blocking agents, 106–9
Beta-agonists, 159, 161–64
Beta-blockers, 106–9
as antihypertensives, 101
asthma, 161
eye drops, 311–13
food interactions, 108
side effects of drugs, 107–8
Beta-carotene, 76